The financing from Sofinnova Partners and Old College Capital will support the launch of precision fibrosis therapeutics.
"Launching Forth Tx through Sofinnova’s biotech accelerator has allowed us to translate years of our multiomics-driven research into precision therapies that we hope will transform patients’ lives. Fibrosis is an area of huge unmet medical need, and I’m delighted to be working with Alex and the Sofinnova team, as well as OCC, to deliver potent, new treatments for patients with fibrosis."
— Neil Henderson, Chair of Tissue Repair and Regeneration at the University of Edinburgh
Manchester United defender Diogo Dalot has backed the health supplement provider with over £841k.
"When it comes to high-level performance, my biggest focus has always been finding that extra 1% — the key to setting myself apart from the rest. Since discovering Bioniq in 2022, it’s been a game-changer for me. I’ve seen the results for myself. Achieving such progress is only possible with a product that’s truly personalized and tailored specifically to my needs. Now, I’m thrilled to take the next step as an investor. I believe in Bioniq’s mission and see the tremendous potential of this business, especially with the growing global demand for personalized nutrition."
Oxford Innovation Finance backs the educational technology provider in its latest funding round.
"Every child deserves to be empowered with the skills they need to thrive in an AI-driven world. This latest round of funding supports our ambitious goals in product development, technological enhancements and market expansion as we aim to reach more students, refine our technology and ensure that every learner has access to high-quality, engaging and effective education. We are excited about the future and remain committed to reshaping the way students prepare for academic success."
The investment was led by 20VC with participation from prominent angel and strategic investors.
"We’ve tried hundreds of tools, very few actually work. Fyxer AI is different. Our team loves it, and more importantly, it gives us an edge. We can now respond faster than our competition, and in Real Estate, the fastest to respond wins. It’s that simple."
The oversubscribed round was led by Bethnal Green Ventures with participation from a group of specialist investors and angels.
"Vouchsafe was one of the standout successes of the CivTech programme, tackling a challenge that affects millions. Their approach to identity verification is a game-changer, making it easier, faster, and more cost-effective for public services to reach those who need them most. This funding is a testament to the impact they are already making, and I’m excited to see how they scale their work to help even more people access vital services."
